Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-24T20:19:03.525Z Has data issue: false hasContentIssue false

Invited commentaries on: Obstetric complications and schizophrenia/affective psychoses

Nature of Obstetric Complications in Schizophrenia

Published online by Cambridge University Press:  02 January 2018

John L. Waddington*
Affiliation:
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, St Stephen's Green, Dublin 2, Ireland. e-mail: jwadding@rcsi.ie
Rights & Permissions [Opens in a new window]

Abstract

Type
Papers
Copyright
Copyright © 2000 The Royal College of Psychiatrists 

NATURE OF OBSTETRIC COMPLICATIONS IN SCHIZOPHRENIA

While Kendell et al (Reference Kendell, McInneny and Juszcaek2000, this issue) are to be commended for reporting what appears to be an artefact that renders their previous study unreliable, their present analyses raise new challenges. These largely (but not entirely) negative findings have to be interpreted in the context of: (a) the three recent birth-cohort studies cited by Kendell et al, each of which reports risk for schizophrenia to be associated significantly with one or more obstetric complication(s); and (b) a recent meta-analysis of 12 previous case-control studies which indicates in schizophrenia an odds ratio of 1.38 (95% CI 1.05-1.84, P=0.02) for exposure to at least one ‘definite’ complication (Reference Geddes, Verdoux and TakeiGeddes et al, 1999).

At a general level, discrepancies between a meta-analysis and a subsequent large, controlled trial are a well-recognised phenomenon in medical research that attract considerable attention; the most parsimonious conclusion in such circumstances is that a discrepant controlled trial does not negate the meta-analytic findings but, rather, suggests heterogeneity between studies that prompts identification and incorporation of covariates which reduce such heterogeneity (Reference DerSimonian and LevineDerSimonian & Levine, 1999). The same principle may be just as applicable to the conundrum of obstetric complications in schizophrenia, but what approach should be taken?

As noted elsewhere (Waddington et al, Reference Waddington, Lane and Larkin1999a ,Reference Waddington, Lane and Scully b ), schizophrenia researchers have concerned themselves overwhelmingly with which and how obstetric complications might impart damage to the nascent nervous system, in the manner of stochastic (random/probablistic) events; conversely, obstetricians adopt a different perspective and vocabulary, concerning themselves equally with what is to them a fundamental issue of why vicissitudes of pregnancy and delivery occur, on the basis that they arise for a reason rather than stochastically. It is enigmatic why many schizophrenia researchers remain preoccupied with the concept of obstetric complications only as a source of direct cerebral insult to a previously normal foetus, when obstetricians themselves readily conceptualise such complications as arising in considerable part due to events acting earlier in pregnancy. Some of their epidemiological findings are of considerable relevance both to schizophrenia and to how the findings of Kendell et al might be accommodated.

Among the general population, complications of late pregnancy and delivery, the period implicated perhaps most consistently (although by no means exclusively) in relation to schizophrenia, are associated with events in early foetal life. For example, breech-birth and cord prolapse are each more common among babies having congenital anomalies, as are bleeding in early pregnancy, pre-eclampsia and premature delivery. Given the origin of congenital anomalies in dysmorphogenesis over embryonic and early foetal life, these findings relate such ‘late’ and other obstetric complications to, and at least in part ‘root’ them in, otherwise unspecified events which have already compromised the foetus over the first or early second trimester (see Waddington et al, Reference Waddington, Lane and Larkin1999a ,Reference Waddington, Lane and Scully b ).

On this basis, as patients with schizophrenia appear to show a characteristic topography of subtle, craniofacial and other dysmorphology (minor physical anomalies/dysmorphic features), arising most likely between weeks 9/10 and 14/15 of gestation, any excess of later obstetric complications therein could reflect an already compromised foetus (Waddington et al, Reference Waddington, Lane and Larkin1999a ,Reference Waddington, Lane and Scully b ); this would be in accordance with Kendell et al quoting that obstetric complications in schizophrenia “appeared to be due largely to characteristics of the child, not the delivery”. There are few data on the relationship between physical anomalies and obstetric complications in schizophrenia, and these are not consistent (Reference O'Callaghan, Larkin and KinsellaO'Callaghan et al, 1991; Reference McNeil and Cantor-GraaeMcNeil & Cantor-Graae, 1999). However, in focusing on the prior integrity of the conceptus, one might explain differences between studies in terms of developmentally determined severity/chronicity of patient illness in the face of as inherently high threshold/low sensitivity a measure as obstetric complications; it may be relevant that patients in the study of Kendell et al were aged between 18 and 26 years, and diagnosed using ICD-8/9 (World Health Organization, 1974, 1978), in whom severity/chronicity of illness would have been less clear, while the majority of patients in the meta-analysis of Geddes et al (Reference Geddes, Verdoux and Takei1999) were of established chronicity and had been diagnosed according to DSM-III/III-R criteria (American Psychiatric Association, 1980, 1987). Furthermore, it is well recognised, even on meta-analysis (Reference Geddes, Verdoux and TakeiGeddes et al, 1999), that it is difficult to resolve any particular complication(s) as bearing a specific pathological relationship to schizophrenia; this might also be consistent with earlier events leading to diversity of sequelae along the complex time-line of human pregnancy. Such a line of reasoning might explain an apparently small population-attributable fraction for obstetric complications in schizophrenia (Reference Geddes, Verdoux and TakeiGeddes et al, 1999), and would predict further inconsistent findings among diverse patient populations; the ‘true’ picture is likely to become clear only on the continuing application of appropriate meta-analytic techniques, and by further study of what may be antecedent factors.

It should be emphasised that such a perspective in no way diminishes the adverse impact of ‘late’ complications on the nascent brain on an individual patient basis; rather, it focuses attention on earlier, primary events that contribute to the emergence thereof, and on their further adverse impact on an already compromised nervous system. The data of Kendell et al should be seen as an important stimulus for revising our perspectives on the nature of obstetric complications in schizophrenia.

References

American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM–III). Washington, DC: APA.Google Scholar
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM–III–R). Washington, DC: APA.Google Scholar
DerSimonian, R. & Levine, R. J. (1999) Resolving discrepancies between a meta-analysis and a subsequent large controlled trial. Journal of the American Medical Association, 282, 664670.CrossRefGoogle Scholar
Geddes, J. R., Verdoux, H., Takei, N., et al (1999) Schizophrenia and complications of pregnancy and labour: an individual patient data meta-analysis. Schizophrenia Bulletin, 25, 413423.CrossRefGoogle ScholarPubMed
Kendell, R. E., McInneny, K., Juszcaek, E., et al (2000) Obstetric complications and schizophrenia. Two case–control studies based on structured obstetric records. British Journal of Psychiatry, 176, 516522.CrossRefGoogle ScholarPubMed
McNeil, T. F. & Cantor-Graae, E. (1999) Does preexisting abnormality cause labor-delivery complications in fetuses who will develop schizophrenia. Schizophrenia Bulletin, 25, 425435.CrossRefGoogle ScholarPubMed
O'Callaghan, E., Larkin, C., Kinsella, A., et al (1991) Familial, obstetric, and other clinical correlates of minor physical anomalies in schizophrenia. American Journal of Psychiatry, 148, 479483.Google ScholarPubMed
Waddington, J. L., Lane, A., Larkin, C., et al (1999) The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease. Biological Psychiatry, 46, 3139.CrossRefGoogle ScholarPubMed
Waddington, J. L., Lane, A., Scully, P. J., et al (1999) Early cerebro-craniofacial dysmorphogenesis in schizophrenia: a lifetime trajectory model from neurodevelopmental basis to ‘neuroprogressive’ process. Journal of Psychiatric Research, 33, 477489.CrossRefGoogle ScholarPubMed
World Health Organization (1974) Mental Disorders: Glossary and Guide to their Classification in Accordance with the Eighth Revision of the International Classification of Diseases (ICD–8). Geneva: WHO.Google Scholar
World Health Organization (1978) Mental Disorders: Glossary and Guide to their Classification in Accordance with the Ninth Revision of the International Classification of Diseases (ICD–9). Geneva: WHO.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.